|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
in00004484316 |
| 005 |
20191203081203.0 |
| 008 |
950217s1995 nyua b 001 0 eng c |
| 010 |
|
|
|a 95007528
|
| 020 |
|
|
|a 0471588237 (hard cover : acid-free paper)
|
| 035 |
|
|
|a (OCoLC)32094176
|
| 035 |
|
|
|9 AAG6657MS
|
| 035 |
|
|
|z (UtOrBLW)21468
|
| 035 |
|
|
|a 34364
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d NLM
|d UtOrBLW
|
| 049 |
|
|
|a TMVM
|c 1
|
| 050 |
0 |
0 |
|a RC607.A26
|b A345728 1995
|
| 060 |
0 |
0 |
|a 1995 H-742
|
| 060 |
1 |
0 |
|a WC 503.2
|b A288 1995
|
| 069 |
0 |
|
|a 9503774
|
| 082 |
0 |
0 |
|a 616.97/92027
|2 20
|
| 096 |
|
|
|a WC 503.2
|b A288 1995
|
| 245 |
0 |
0 |
|a AIDS clinical trials /
|c edited by Dianne M. Finkelstein, David A. Schoenfeld.
|
| 264 |
|
1 |
|a New York :
|b Wiley-Liss,
|c [1995]
|
| 264 |
|
4 |
|c ©1995
|
| 300 |
|
|
|a xiv, 458 pages :
|b illustrations ;
|c 24 cm.
|
| 336 |
|
|
|a text
|2 rdacontent
|b txt
|
| 337 |
|
|
|a unmediated
|2 rdamedia
|
| 338 |
|
|
|a volume
|2 rdacarrier
|b nc
|
| 500 |
|
|
|a On cover: Guidelines for design and analysis.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 590 |
|
|
|a copy plain
|
| 505 |
0 |
|
|a Introduction -- The natural history of the HIV infection: Implications for clinical trials -- The new drug evaluation process: FDA perspective -- The new drug evaluation process: Industry perspective -- Protocol development -- Data issues in AIDS clinical trials -- Current methods and future trends in the design and analysis of phase I and phase I/II clinical trials in AIDS -- Selection of endpoints for assessment of treatment efficacy in an AIDS trial -- The uses of CD4 lymphocyte count to evaluate therapy for HIV disease -- Sample size calculations for failure time data -- The design and analysis of equivalence trials -- Interim monitoring of clinical trials -- Behavioral science and the design and conduct of randomized AIDS trials -- Compliance in AIDS clinical trials.
|
| 505 |
0 |
|
|a Quality-of-life considerations in AIDS clinical trials -- Issues in analysis of AIDS clinical trials -- Issues in the testing of drug combinations -- Issues in the conduct of clinical trials for HIV-infected children.
|
| 505 |
0 |
|
|a Clinical trials to reduce the risk of maternal-infant transmission of HIV infection -- Obstetrical and gynecological issues in AIDS clinical trials -- Prophylactic HIV vaccine trials -- Large simple trials of HIV therapies -- Economic analysis and AIDS clinical research -- Use of observational data for evaluating AIDS therapies -- Use of cohort studies for evaluating AIDS therapies.
|
| 650 |
|
2 |
|a Acquired Immunodeficiency Syndrome
|x drug therapy.
|
| 650 |
|
2 |
|a Clinical Trials as Topic
|x methods.
|
| 650 |
|
2 |
|a Research Design.
|
| 700 |
1 |
|
|a Finkelstein, Dianne M.
|
| 700 |
1 |
|
|a Schoenfeld, David A.
|
| 948 |
|
|
|a Retain per EC; 2002 evaluation; nb, 09/09/2002.
|
| 999 |
|
|
|a MARS
|
| 999 |
f |
f |
|s ce7b0fc3-f205-36fa-beb9-bdeadf947bf5
|i c2c22a6a-2544-39c8-b2a7-763173bb557f
|t 0
|
| 952 |
f |
f |
|p ric
|a Texas A&M University
|b Rellis Campus
|c Joint Library Facility
|d Remote Storage
|t 0
|e WC 503.2 A288 1995
|h Other scheme
|i unmediated -- volume
|m 3238901189528
|
| 998 |
f |
f |
|a WC 503.2 A288 1995
|t 0
|l Remote Storage
|